Berliner Boersenzeitung - New US strategy to make monkeypox vaccine go further

EUR -
AED 4.212777
AFN 72.835586
ALL 94.512843
AMD 422.248264
ANG 2.053494
AOA 1052.895931
ARS 1680.790338
AUD 1.635257
AWG 2.067368
AZN 1.95436
BAM 1.956354
BBD 2.309354
BDT 140.73988
BGN 1.939347
BHD 0.432422
BIF 3423.630825
BMD 1.146945
BND 1.480319
BOB 7.92328
BRL 5.90941
BSD 1.146625
BTN 108.087801
BWP 15.582008
BYN 3.185903
BYR 22480.122
BZD 2.305963
CAD 1.623185
CDF 2615.035015
CHF 0.925648
CLF 0.026299
CLP 1035.072439
CNY 7.764364
CNH 7.780559
COP 3960.034063
CRC 520.14739
CUC 1.146945
CUP 30.394043
CVE 110.569964
CZK 24.190336
DJF 203.835517
DKK 7.474072
DOP 66.986043
DZD 152.939427
EGP 57.331754
ERN 17.204175
ETB 181.647461
FJD 2.564
FKP 0.866759
GBP 0.866531
GEL 3.039852
GGP 0.866759
GHS 12.874504
GIP 0.866759
GMD 84.304874
GNF 10064.442782
GTQ 8.746478
GYD 239.84901
HKD 8.988436
HNL 30.606273
HRK 7.533254
HTG 149.77244
HUF 351.906109
IDR 20445.785654
ILS 3.394682
IMP 0.866759
INR 108.1919
IQD 1502.49795
IRR 1577049.375404
ISK 143.976448
JEP 0.866759
JMD 181.171337
JOD 0.813229
JPY 185.008009
KES 148.419043
KGS 100.300781
KHR 4599.249852
KMF 492.617229
KPW 1032.250901
KRW 1752.130969
KWD 0.353179
KYD 0.955446
KZT 559.543917
LAK 25295.872375
LBP 102708.92515
LKR 382.668433
LRD 208.916469
LSL 18.815678
LTL 3.386631
LVL 0.693776
LYD 7.311819
MAD 10.580612
MDL 20.248208
MGA 4817.169398
MKD 61.628611
MMK 2407.987936
MNT 4106.547494
MOP 9.256923
MRU 45.947051
MUR 54.881752
MVR 17.720734
MWK 1992.243861
MXN 19.872547
MYR 4.745948
MZN 73.301688
NAD 18.814173
NGN 1560.350288
NIO 41.990088
NOK 11.102662
NPR 172.945006
NZD 1.997675
OMR 0.441554
PAB 1.14663
PEN 3.881306
PGK 5.032508
PHP 69.638491
PKR 319.223511
PLN 4.259467
PYG 7041.056554
QAR 4.175458
RON 5.239364
RSD 117.183799
RUB 83.845404
RWF 1679.12748
SAR 4.299026
SBD 9.24601
SCR 15.693948
SDG 688.744688
SEK 10.98638
SGD 1.482316
SHP 0.85631
SLE 28.387314
SLL 24050.86738
SOS 655.483268
SRD 42.898615
STD 23739.445827
STN 24.544623
SVC 10.032843
SYP 126.774237
SZL 18.814083
THB 37.723444
TJS 10.63456
TMT 4.014308
TND 3.339618
TOP 2.761569
TRY 53.262066
TTD 7.775237
TWD 36.375404
TZS 3017.595134
UAH 51.508996
UGX 4173.182519
USD 1.146945
UYU 45.84299
UZS 13769.075108
VES 695.774297
VND 30176.12295
VUV 135.491976
WST 3.156157
XAF 656.142926
XAG 0.017685
XAU 0.000276
XCD 3.099677
XCG 2.066386
XDR 0.807102
XOF 648.024305
XPF 119.331742
YER 273.665193
ZAR 18.876464
ZMK 10323.885445
ZMW 20.552914
ZWL 369.315822
  • CMSC

    0.0500

    22.37

    +0.22%

  • CMSD

    0.0000

    22.29

    0%

  • NGG

    -1.2400

    79.44

    -1.56%

  • RIO

    -2.5900

    100.08

    -2.59%

  • BCE

    0.0000

    23.28

    0%

  • BCC

    3.8500

    74.66

    +5.16%

  • BP

    -1.0400

    39.1

    -2.66%

  • RBGPF

    -0.5300

    60.61

    -0.87%

  • BTI

    -0.5800

    58.91

    -0.98%

  • GSK

    -1.4800

    50.67

    -2.92%

  • AZN

    -2.9600

    174.93

    -1.69%

  • RYCEF

    -0.0300

    18.4

    -0.16%

  • JRI

    0.0500

    12.67

    +0.39%

  • VOD

    -0.2300

    14.3

    -1.61%

  • RELX

    -0.8300

    31.18

    -2.66%

New US strategy to make monkeypox vaccine go further
New US strategy to make monkeypox vaccine go further / Photo: Patrick T. FALLON - AFP

New US strategy to make monkeypox vaccine go further

US health authorities on Tuesday authorized a new procedure for injecting the monkeypox vaccine that should make it possible to inoculate more people with the same amount of the drug, at a time when doses are running short in the country.

Text size:

The Food and Drug Administration also authorized giving the vaccine to people under the age of 18 who are considered to be at high risk of infection.

For those over 18, health workers will now be able to administer the vaccine differently, via an intradermal injection -- that is, between the upper layers of the skin -- and not with a deeper, subcutaneous injection.

The new method will "increase the total number of doses available for use by up to five-fold," the FDA said in a statement.

Two injections, four weeks apart, will still be necessary.

The FDA said it was drawing on data from a 2015 clinical trial that showed a similar immune response in people given a subcutaneous injection compared to those given a fifth of the dose via an intradermal shot.

At present, some 620,000 doses of the vaccine -- manufactured by Bavarian Nordic, and marketed under the name Jynneos in the United States -- have been distributed across the country.

Another 440,000 additional doses are still to be distributed, which could allow up to 2.2 million injections under the new strategy.

The government has also ordered an additional five million doses, which will start arriving from September and run through 2023, affording the potential to administer 25 million doses.

The decisions came after the FDA issued an emergency use authorization for the vaccine, a move that itself followed the declaration of a public health emergency last week.

For the authorization in minors, the FDA said it had reviewed safety data for the vaccine, as well as data for another vaccine given in children against smallpox.

"We feel very comfortable with the safety of the approach," said Peter Marks of the FDA at a press conference, noting a recent increase in the number of children who have potentially been exposed to infected people.

The United States has registered nearly 9,000 cases of monkeypox, a fifth of them in New York state. The vast majority of cases involve men who have had sex with men.

(K.Lüdke--BBZ)